NB-UVB phototherapy for generalized granuloma annulare

Mor Pavlovsky*, Liat Samuelov, Eli Sprecher, Hagit Matz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Granuloma annulare (GA) is a benign, usually self-limited, granulomatous skin disease of unknown etiology. The generalized form of the disease shows a more chronic, relapsing course, rare spontaneous resolution, and poorer response to therapy. Psoralen plus UVA phototherapy has been reported to be effective for GA. However, little is known regarding the efficacy of narrowband UVB phototherapy. Our goal was to determine the efficacy of NB-UVB phototherapy in generalized GA. We carried out a retrospective study of patients with generalized GA treated with NB-UVB phototherapy over a period of 3 years. On completion of treatment, outcome was assessed as complete response (complete clearance of the lesions), partial response (>50% clearance of the lesions), and poor response (<50% clinical response). Therapy was stopped if no improvement was seen after 20 treatments. Thirteen patients were included in the study. 54% of patients treated with NB-UVB had a complete/partial response by the end of the treatment period. NB-UVB phototherapy was well-tolerated, with no serious adverse effects. NB-UVB phototherapy is effective in a substantial portion of patients with generalized GA. To determine the true efficacy of this therapeutic modality, a prospective study comparing it to PUVA is warranted.

Original languageEnglish
Pages (from-to)152-154
Number of pages3
JournalDermatologic Therapy
Issue number3
StatePublished - 1 May 2016
Externally publishedYes


  • histiocytic disorders
  • phototherapy


Dive into the research topics of 'NB-UVB phototherapy for generalized granuloma annulare'. Together they form a unique fingerprint.

Cite this